Carcinoembryonic antigen (CEA), technical only
Use
Carcinoembryonic antigen (CEA) is an epithelial marker used to assist in the distinction between adenocarcinoma and mesotheliomas. CEA is also useful for identifying the origin of various metastatic adenocarcinomas when used in a panel of antibodies. Technical component only. Pathologist read not included.
Special Instructions
Not provided.
Limitations
Technical component only. Pathologist read not included. Specimens must be fixed in 10% NBF or B plus. All other fixatives will be rejected.
Methodology
Immunoassay (IHC)
Biomarkers
Carcinoembryonic antigen
Protein
Result Turnaround Time
2 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Fixed (Non-FFPE))
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Fixative should be at a 20:1 fixative to tissue ratio, 10% neutral buffered formalin (NBF) for 6-72 hours (48-72 hours PREFERRED).
Causes for Rejection
All other fixatives will be rejected.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | ≤ 72 Hours |